Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Achilles Tendinopathy

Back to Topics
Contents
0%

Achilles Tendinopathy

Comprehensive guide to achilles tendinopathy including insertional and non-insertional types, eccentric exercise protocols, imaging, and surgical management for Orthopaedic examination

complete
Updated: 2025-12-19
High Yield Overview

ACHILLES TENDINOPATHY

Degenerative Tendinosis | Insertional vs Mid-Portion | Eccentric Loading | FHL Transfer

2-6cmWatershed zone (mid-portion)
12wkEccentric protocol duration
70-90%Non-op success rate
50%Threshold for FHL transfer

LOCATION-BASED CLASSIFICATION

Insertional
PatternAt calcaneal attachment
TreatmentDebridement, Haglund resection, suture anchor repair
Non-insertional (Mid-portion)
Pattern2-6cm proximal to insertion
TreatmentEccentric exercises, debridement, FHL transfer if needed
Paratendinopathy
PatternSurrounding paratenon inflammation
TreatmentStripping, debridement of adhesions

Critical Must-Knows

  • Degenerative tendinosis - NOT tendinitis (minimal inflammation)
  • Watershed zone 2-6cm proximal to insertion has poorest blood supply
  • Eccentric exercises are first-line (Alfredson: 2x15 reps, twice daily, 12 weeks)
  • Steroids contraindicated - increased rupture risk
  • FHL transfer if debriding more than 50% of tendon cross-section

Examiner's Pearls

  • "
    Neovascularization with nerve ingrowth causes pain
  • "
    Arc sign: pain moves with ankle dorsiflexion in mid-portion disease
  • "
    Thompson test normal (rules out complete rupture)
  • "
    Insertional disease has worse prognosis than mid-portion

Clinical Imaging

Imaging Gallery

Power Doppler ultrasound showing neovascularization in Achilles tendinopathy
Click to expand
Power Doppler ultrasound demonstrating neovascularization of the ventral aspect of the Achilles tendon - a pathognomonic finding in mid-portion tendinopathy. The color signal indicates blood flow in newly formed vessels that accompany nerve ingrowth, explaining the source of chronic pain. This finding correlates with symptom severity and can guide targeted treatments like high-volume injection or surgical stripping.Credit: van Sterkenburg et al. - CC BY 4.0
MRI showing Achilles tendon rupture
Click to expand
Sagittal MRI of the ankle demonstrating acute Achilles tendon rupture (arrow). The tendon discontinuity is clearly visible with surrounding fluid and edema. MRI is useful for distinguishing complete from partial tears and assessing the gap distance - important for surgical planning. Note the typical location in the watershed zone 2-6cm proximal to the calcaneal insertion.Credit: Open-i/NIH - CC BY 4.0

Critical Achilles Tendinopathy Exam Points

Tendinosis NOT Tendinitis

Failed healing response with disordered collagen (Type I replaced by Type III), mucoid degeneration, and neovascularization with nerve ingrowth. Minimal inflammatory cells present. This is why NSAIDs have limited benefit.

Location Matters

Mid-portion (2-6cm): Watershed zone, better prognosis with eccentric exercises. Insertional: Often associated with Haglund deformity and retrocalcaneal bursitis, responds less well to conservative treatment.

Steroid Contraindication

Never inject corticosteroids into or around the Achilles tendon. Associated with tendon rupture risk. Peritendinous injections may cause skin atrophy and have limited benefit.

Surgical Threshold

Surgical debridement for refractory cases after 6 months conservative treatment. If more than 50% tendon debridement needed, augment with FHL transfer. Gastrocnemius recession if equinus contracture.

Achilles Tendinopathy At a Glance

ParameterMid-Portion (Non-insertional)Insertional
Location2-6cm proximal to insertionAt calcaneal attachment
Incidence55-65% of cases20-25% of cases
PathologyTendinosis in watershed zoneEnthesopathy, often with Haglund
Arc signPositive (pain moves with ankle)Negative (pain fixed at insertion)
Conservative success70-90%50-60%
Eccentric exercisesHighly effectiveLess effective, may exacerbate
Surgical approachMedial or posterior midlineCentral tendon-splitting
AugmentationFHL transfer if more than 50% debridementSuture anchor repair, FHL rarely needed
Mnemonic

TENDON - Pathophysiology

T
Type III collagen
Replaces normal Type I collagen
E
Endothelial proliferation
Neovascularization with nerve ingrowth
N
No inflammation
Tendinosis, NOT tendinitis
D
Degeneration
Mucoid, lipoid, and calcific changes
O
Oxygen-poor zone
Watershed area 2-6cm from insertion
N
Nerve ingrowth
Accompanies vessels, causes pain

Memory Hook:TENDON reminds you this is degenerative disease with vascular and nerve changes, not acute inflammation

Mnemonic

ALFREDSON - Eccentric Protocol

A
Achilles loading
Eccentric (lengthening) contractions
L
Long duration
12 weeks minimum commitment
F
Fifteen repetitions
2 sets of 15 reps per session
R
Repeat twice daily
Morning and evening sessions
E
Edge of step
Heel drop off step edge
D
Discomfort expected
Continue through moderate pain
S
Straight and bent knee
Both positions for complete treatment
O
Only eccentric phase
Rise on unaffected leg
N
No concentric work
Push up with good side only

Memory Hook:Remember the ALFREDSON protocol creator - 2x15 reps, twice daily, 12 weeks

Mnemonic

DEBRIDE - Surgical Indications

D
Duration over 6 months
Conservative treatment failure
E
Exercise failure
Compliant eccentric program
B
Bilateral disease
More likely to need surgery
R
Radiographic changes
Calcification, Haglund deformity
I
Impaired function
Unable to return to activities
D
Degenerative changes on MRI
Extensive tendinosis
E
Elite athlete needs
Expedited treatment pathway

Memory Hook:DEBRIDE when conservative treatment fails after proper duration

Mnemonic

50% Rule for FHL Transfer

50
Fifty percent threshold
Percentage of tendon requiring debridement
%
Cross-sectional area
Measured intraoperatively

Memory Hook:More than 50% tendon debridement = FHL transfer for augmentation

Overview and Epidemiology

Achilles tendinopathy is a degenerative overuse condition affecting the body's largest and strongest tendon. It represents a spectrum of tendon pathology from early reactive change to advanced degenerative disease.

Key epidemiological features:

  • Running athletes: 6-18% lifetime incidence
  • Jumping sports: Basketball, volleyball, tennis at higher risk
  • Age distribution: Peak 30-50 years, but can occur at any age
  • Bilateral involvement: 30% of cases

Risk factors:

  • Training errors (rapid increase in intensity/duration)
  • Biomechanical factors (hindfoot varus/valgus, equinus contracture)
  • Fluoroquinolone antibiotics (10-fold increased risk)
  • Systemic conditions (diabetes, obesity, hypercholesterolemia)
  • Footwear changes
  • Male gender (for rupture, not tendinopathy)

Terminology Matters

Use "tendinopathy" as the clinical diagnosis when symptoms and examination suggest tendon pathology. "Tendinosis" refers to the histological finding of degenerative change without inflammation. "Tendinitis" implies inflammation which is rarely the primary process.

Pathophysiology and Mechanisms

The Achilles tendon is formed by the confluence of the gastrocnemius and soleus tendons approximately 15cm proximal to its insertion on the posterior calcaneal tuberosity.

Structural anatomy:

  • Length: Approximately 15cm from musculotendinous junction to insertion
  • Width: 6-8cm at musculotendinous junction, narrowing to 1.5-2cm at insertion
  • Rotation: Fibers rotate 90 degrees along length (lateral gastrocnemius inserts posteromedially)
  • Paratenon: Loose connective tissue sheath without synovial lining
  • Cross-sectional area: Approximately 60-80 mm²

Blood supply (critical for understanding pathology):

  • Proximal: Muscular branches from gastrocnemius and soleus
  • Middle (watershed zone): Peritendinous vessels - relatively hypovascular
  • Distal: Calcaneal vessels via osseous insertion

Watershed Zone

The zone 2-6cm proximal to insertion has the poorest blood supply and is where most mid-portion tendinopathy occurs. This relative hypovascularity contributes to impaired healing and is the target zone for eccentric exercise therapy.

Biomechanics:

  • Forces during running: 6-8x body weight
  • Elongation: 6-8% during normal gait
  • Storage of elastic energy: 35% of energy during running stored in Achilles
  • Gastrocnemius: Primarily ankle plantarflexion, active with knee extended
  • Soleus: Plantarflexion active regardless of knee position

Associated structures:

  • Retrocalcaneal bursa: Between tendon and calcaneus (inflamed in insertional disease)
  • Haglund deformity: Posterosuperior calcaneal prominence causing impingement
  • Kager's fat pad: Pre-Achilles fat triangle (obliterated in rupture)
  • Plantaris tendon: Runs medial to Achilles, may contribute to medial symptoms

Classification Systems

Primary Classification (Clinically Most Useful)

TypeLocationKey FeaturesPrognosis
Non-insertional (Mid-portion)2-6cm from insertionWatershed zone, fusiform thickening, positive arc signBetter (70-90% non-op success)
InsertionalAt calcaneal attachmentOften with Haglund, may have calcification, fixed tendernessWorse (50-60% non-op success)
ParatendinopathyParatenon surrounding tendonCrepitus, linear thickening on imaging, acute presentationGood with activity modification

Approximately 20-25% of cases have combined insertional and non-insertional disease.

Cook and Purdam Continuum Model (2009)

StagePathologyImagingTreatment Response
Reactive tendinopathyNon-inflammatory proliferative responseThickening, no structural changeExcellent with load modification
Tendon disrepairGreater matrix breakdown, some neovascularizationFocal hypoechoic areasGood with eccentric loading
Degenerative tendinopathyExtensive matrix disorganization, cell deathExtensive tendinosis, possible partial tearsMay require surgery

This model emphasizes the spectrum of disease and that early stages are reversible.

Astrom Classification (MRI-based)

GradeMRI FindingsClinical Correlation
Grade 0Normal tendon signalNormal or subclinical
Grade IMinor signal increase on T1 and T2Early tendinopathy
Grade IIAbnormal morphology with increased signalEstablished tendinopathy
Grade IIIHigh signal on T2 indicating partial tearPartial tear or severe disease

MRI grade correlates with treatment outcomes and surgical findings.

Clinical Assessment

History:

  • Location of pain: Mid-portion vs insertional
  • Onset: Usually gradual (acute suggests paratendinopathy or rupture)
  • Morning stiffness: Characteristic of tendinopathy (improves with activity)
  • Activity relationship: Worse with activity, especially running and jumping
  • Training history: Recent changes in intensity, duration, or footwear
  • Previous treatment: Physiotherapy, injections, medications
  • Risk factors: Fluoroquinolones, diabetes, systemic diseases

Examination:

Clinical Tests

TestTechniquePositive FindingSignificance
PalpationSystematic palpation along tendonTenderness, thickening, nodulesLocalizes pathology
Arc signPalpate tender area while dorsiflexing ankleTenderness moves with ankle motionMid-portion disease (positive) vs insertional (negative)
Thompson testSqueeze calf with patient prone, knee flexedNo plantarflexion = positive = ruptureMust be NORMAL in tendinopathy (rules out complete rupture)
Single-heel raiseRise onto toes on affected legUnable or painfulFunctional assessment
Royal London Hospital testPain on palpation decreases with ankle dorsiflexionPain relief with stretchSuggests mid-portion tendinopathy

Arc Sign Distinction

Arc sign positive: Tenderness moves with ankle dorsiflexion indicating mid-portion disease. Arc sign negative: Fixed tenderness at insertion regardless of ankle position indicating insertional disease. This distinction guides treatment selection.

Biomechanical assessment:

  • Hindfoot alignment (varus/valgus)
  • Gastrocnemius tightness (Silfverskiold test)
  • Foot posture (pronation/supination)
  • Gait analysis
  • Footwear assessment

Investigations

First-line imaging modality

Findings in tendinopathy:

  • Tendon thickening (greater than 6mm AP diameter abnormal)
  • Hypoechoic areas (degenerative regions)
  • Loss of normal fibrillar pattern
  • Neovascularization on Power Doppler
  • Paratenon thickening in paratendinopathy

Advantages:

  • Dynamic assessment
  • Comparison with contralateral side
  • Cost-effective
  • Guides injections
  • Power Doppler for neovascularization assessment

Ultrasound findings correlate well with symptoms and can guide treatment targeting areas of neovascularization.

Gold standard for comprehensive assessment

Typical findings:

  • T1: Thickened tendon with normal or slightly increased signal
  • T2/STIR: Increased signal within tendon substance
  • Fusiform thickening in mid-portion disease
  • Insertional spurring and retrocalcaneal bursitis in insertional type
  • Partial tear: High T2 signal with partial thickness defect

Advantages:

  • Superior soft tissue contrast
  • Detects partial tears accurately
  • Assesses bone pathology (Haglund, calcaneal edema)
  • Preoperative planning

Limitations:

  • Cost
  • Static imaging only
  • May overestimate pathology

Despite these limitations, MRI remains valuable for comprehensive preoperative assessment.

Role in insertional disease:

  • Haglund deformity (parallel pitch lines)
  • Insertional calcification
  • Retrocalcaneal spurring
  • Parallel pitch lines: Lines drawn parallel to sole through highest point of posterior calcaneal tuberosity should not project into retrocalcaneal bursa

Limited value in mid-portion tendinopathy but useful for insertional disease assessment.

Management Algorithm

📊 Management Algorithm
Achilles tendinopathy management algorithm flowchart
Click to expand
Treatment algorithm: Mid-portion disease (eccentric exercises, 70-90% success) vs Insertional disease (modified protocol, 50-60% success). Surgical debridement with FHL transfer if more than 50% tendon debridement required.Credit: OrthoVellum

Eccentric Exercise Protocol (Alfredson)

Protocol details:

  • 2 sets of 15 repetitions
  • Twice daily (morning and evening)
  • 12 weeks minimum duration
  • Straight knee (gastrocnemius) AND bent knee (soleus)
  • Progress through moderate discomfort (pain level 4-5/10)
  • Add load as pain decreases

Adjunctive treatments:

  • GTN patches (nitroglycerin): May improve collagen synthesis
  • ESWT: 3 sessions, 2000 impulses per session
  • Heel lifts: Reduce strain on tendon
  • Activity modification: Reduce provocative activities temporarily
  • Biomechanical correction: Orthotics if foot posture abnormal

What NOT to do:

  • Corticosteroid injections (rupture risk)
  • Complete rest (deloading harmful)
  • Aggressive stretching acutely

Conservative treatment is more effective for mid-portion disease than insertional disease.

Indications:

  • Failed conservative treatment (6+ months)
  • Unable to return to desired activity level
  • Progressive symptoms despite treatment

Mid-portion procedures:

  • Open debridement through medial or posterior midline approach
  • Paratenon stripping
  • Longitudinal tenotomies
  • FHL transfer if more than 50% tendon debridement
  • Gastrocnemius recession if equinus contracture

Insertional procedures:

  • Central tendon-splitting approach
  • Debridement of insertional calcification
  • Haglund resection
  • Retrocalcaneal bursectomy
  • Suture anchor repair of detached tendon
  • FHL transfer less commonly needed

Surgical success rates: 75-85% good/excellent outcomes.

Surgical Technique

Approach and Positioning:

  • Prone position, tourniquet at thigh
  • Medial or posterior midline incision
  • Medial approach preferred to protect sural nerve laterally

Steps:

Mid-Portion Debridement Steps

Step 1Exposure

Make 8-10cm longitudinal incision centered on pathological area. Incise paratenon longitudinally. Identify and protect sural nerve if using lateral approach.

Step 2Debridement

Identify degenerative tissue (yellow, soft, mucoid appearance). Excise all abnormal tissue with knife or curette. May need to split tendon longitudinally to access central disease.

Step 3Assessment

Assess remaining tendon cross-section. If more than 50% debrided, plan FHL transfer for augmentation.

Step 4Repair

Close tendon defect with side-to-side repair if possible. Use non-absorbable suture (2-0 Ethibond or similar).

Step 5Closure

Close paratenon if possible. Layered skin closure. Apply well-padded splint in slight plantarflexion.

If gastrocnemius recession needed, perform through same or separate incision at musculotendinous junction.

Indication: More than 50% tendon requires debridement

Rationale:

  • FHL is in phase with Achilles (plantarflexor)
  • Similar muscle fiber type
  • Excellent tendon quality and length
  • Minimal donor site morbidity
  • Brings new blood supply

FHL Transfer Steps

Step 1Exposure

Extended medial approach to Achilles and distal FHL. Identify FHL muscle belly in Kager's fat pad, deep to Achilles.

Step 2Harvest

Follow FHL tendon to Henry's knot (decussation with FDL). Divide FHL tendon distal to knot. Free tendon proximally.

Step 3Tunnel

Create drill hole in calcaneus from medial to lateral. Size to accommodate FHL tendon (usually 6mm).

Step 4Transfer

Pass FHL tendon through calcaneal tunnel. Fix with interference screw or suture button with ankle in 20 degrees plantarflexion.

Step 5Tensioning

Tension FHL with ankle at 20 degrees plantarflexion. Suture FHL to Achilles stump if possible for additional security.

Toe flexion weakness is minimal and usually not noticeable to patients.

Central tendon-splitting approach:

  • J-shaped or inverted U incision over insertion
  • Split tendon longitudinally in midline
  • Debride degenerative tissue and calcification
  • Resect Haglund prominence if present
  • Excise retrocalcaneal bursa
  • Reattach tendon with suture anchors

If more than 50% of insertion detached, use 2-3 suture anchors for reattachment. Consider FHL transfer for significant detachment.

Indication: Isolated gastrocnemius contracture (Silfverskiold positive)

Strayer procedure:

  • Medial or posterior incision at musculotendinous junction
  • Identify gastrocnemius aponeurosis
  • Transversely divide aponeurosis
  • Allow gastrocnemius to slide distally
  • Do not repair - allow healing in lengthened position

Baumann procedure:

  • Proximal gastrocnemius release at muscle origin
  • Less cosmetic scarring
  • Similar outcomes

May be combined with Achilles debridement for comprehensive treatment of equinus-related tendinopathy.

Complications

Eccentric exercise complications:

  • Transient increased pain (expected, should continue)
  • Calf muscle soreness
  • Rare: partial rupture if pre-existing weakening

Treatment failures:

  • 10-30% of mid-portion cases
  • 40-50% of insertional cases
  • May require eventual surgery

Non-operative complications are generally minor and self-limiting.

Early complications:

  • Wound healing problems (5-10%) - higher in insertional surgery
  • Sural nerve injury (lateral approach)
  • Deep vein thrombosis
  • Infection (1-2%)

Late complications:

  • Tendon rupture (rare, typically early postoperative)
  • Persistent pain (10-20%)
  • Weakness (usually mild and temporary)
  • Adhesions and stiffness
  • Recurrence of symptoms

FHL transfer-specific:

  • Toe flexion weakness (minimal)
  • Neurovascular injury during harvest
  • Transfer failure (rare)

Insertional surgery-specific:

  • Wound breakdown (higher risk due to location)
  • Avascular necrosis of calcaneal tuberosity (rare)
  • Re-detachment requiring revision

Overall surgical complication rate is approximately 10-15%.

Postoperative Care

Simple debridement (less than 50% tendon):

Rehabilitation Phases

ImmobilizationWeeks 0-2

Below-knee cast or boot. Non-weight bearing. Elevation and ice.

Early MotionWeeks 2-6

Weight bearing in boot. Begin gentle ROM exercises out of boot. Physiotherapy for ankle mobility.

Progressive LoadingWeeks 6-12

Wean from boot. Progressive weight bearing. Begin eccentric exercises at 8 weeks. Stationary cycling.

Return to ActivityWeeks 12-24

Sport-specific rehabilitation. Running progression from week 16. Full activity 4-6 months.

Earlier rehabilitation leads to better outcomes than prolonged immobilization.

Extended protocol for tendon transfer:

  • Weeks 0-6: Boot with heel wedges, progressive weight bearing
  • Weeks 6-12: Wean boot, begin physiotherapy
  • Week 8: Start eccentric exercises
  • Week 12: Begin running progression
  • Months 6-9: Return to full activity

Key differences from simple debridement:

  • Longer protection period
  • Slower progression of loading
  • Greater attention to toe flexion exercises
  • Later return to sport

FHL transfer adds approximately 6-8 weeks to overall recovery timeline.

Slower progression due to tendon reattachment:

  • Weeks 0-4: Non-weight bearing, splint/cast
  • Weeks 4-8: Weight bearing in boot
  • Weeks 8-12: Wean boot, physiotherapy
  • Week 12: Begin eccentric exercises
  • Months 4-6: Running progression
  • Months 6-9: Full activity

Insertional surgery requires longer protection to allow bone-tendon healing at suture anchor sites.

Outcomes and Prognosis

Treatment Outcomes Summary

TreatmentSuccess RateReturn to SportRecurrence
Eccentric exercises (mid-portion)70-90%3-6 months10-20%
Eccentric exercises (insertional)50-60%4-8 months20-30%
ESWT adjunct+10-15%3-6 monthsSimilar to eccentric alone
Surgical debridement75-85%6-9 months5-10%
FHL transfer80-90%9-12 monthsLess than 5%

Prognostic factors:

Factors Affecting Outcomes

FactorBetter PrognosisWorse Prognosis
LocationMid-portionInsertional
DurationLess than 3 monthsGreater than 12 months
AgeUnder 40 yearsOver 50 years
Activity levelRecreational athleteSedentary or elite athlete
ComplianceFull eccentric protocolIncomplete exercise program
MRI gradeGrade I-IIGrade III (partial tear)
Previous treatmentFirst presentationMultiple failed treatments

Long-term outcomes are generally good with appropriate treatment matching. Patient education about the chronic nature and need for sustained rehabilitation is essential.

Evidence Base

Eccentric Exercise Effectiveness

I
📚 Alfredson et al. Am J Sports Med 1998; Multiple systematic reviews
Key Findings:
  • 82% success rate with eccentric protocol
  • Pain reduction from 7/10 to 2/10 average
  • Effect maintained at 5-year follow-up
  • Most effective for mid-portion disease
Clinical Implication: Eccentric exercises are first-line treatment for non-insertional Achilles tendinopathy. Protocol compliance is essential for success.

Eccentric vs Heavy Slow Resistance

I
📚 Beyer et al. Am J Sports Med 2015
Key Findings:
  • Similar clinical outcomes at 12 weeks
  • Higher patient satisfaction with heavy slow resistance
  • 3 sessions per week vs daily eccentric
  • Both superior to wait-and-see approach
Clinical Implication: Heavy slow resistance may be an alternative to traditional eccentric protocol with better compliance.

Insertional vs Non-insertional Outcomes

II
📚 Wiegerinck et al. Knee Surg Sports Traumatol Arthrosc 2013
Key Findings:
  • 50% success insertional vs 70-90% mid-portion
  • Insertional more likely to need surgery
  • Eccentric exercises may exacerbate insertional symptoms
  • Different treatment protocols may be needed
Clinical Implication: Location-specific treatment protocols are essential. Insertional disease may require earlier surgical consideration.

FHL Transfer Outcomes

III
📚 Den Hartog BD. Foot Ankle Int 2003; Multiple case series
Key Findings:
  • 80-90% patient satisfaction
  • Minimal functional toe flexion weakness
  • Brings blood supply to degenerative area
  • Indicated for greater than 50% debridement
Clinical Implication: FHL transfer is the augmentation of choice when extensive debridement compromises tendon integrity.

Corticosteroid Injection Risks

III
📚 Systematic reviews and case series
Key Findings:
  • Increased rupture risk with peritendinous injection
  • No long-term pain reduction
  • Rupture risk highest in first 4 weeks post-injection
  • Should be avoided in Achilles tendinopathy
Clinical Implication: Corticosteroid injections are contraindicated in Achilles tendinopathy. This is a common exam trap.

Exam Viva Scenarios

Practice these scenarios to excel in your viva examination

VIVA SCENARIOStandard

Scenario 1: Mid-Portion Tendinopathy

EXAMINER

"A 35-year-old recreational runner presents with 6 months of posterior heel pain, 4cm above the heel. Pain is worse in the morning and improves with warming up. He has tried rest and NSAIDs without improvement. Examination shows fusiform thickening with tenderness that moves when you dorsiflex the ankle."

EXCEPTIONAL ANSWER
This presentation is consistent with mid-portion Achilles tendinopathy, supported by the classic location 4cm proximal to insertion, morning stiffness improving with activity, and a positive arc sign where tenderness moves with ankle dorsiflexion. The failed response to rest and NSAIDs is expected as this is a degenerative tendinosis rather than inflammatory tendinitis. My initial management would be eccentric exercise therapy using the Alfredson protocol - 2 sets of 15 repetitions, twice daily, for 12 weeks, performed with both straight and bent knee. I would explain that some discomfort is expected during exercises. I would add adjunctive treatments including activity modification, heel lifts, and consider GTN patches. I would avoid corticosteroid injections due to rupture risk. If symptoms persist after 3 months of compliant eccentric exercises, I would arrange imaging with ultrasound or MRI to assess the degree of tendinosis and consider surgical debridement if conservative treatment fails after 6 months.
KEY POINTS TO SCORE
Arc sign distinguishes mid-portion from insertional disease
Eccentric exercises are first-line treatment
12-week protocol required for adequate trial
Steroids contraindicated due to rupture risk
COMMON TRAPS
✗Injecting corticosteroids
✗Prescribing complete rest (causes deconditioning)
✗Not specifying the eccentric protocol details
✗Operating before adequate conservative trial
LIKELY FOLLOW-UPS
"What if MRI shows a partial tear?"
"How would management differ if this was insertional disease?"
"When would you consider FHL transfer?"
VIVA SCENARIOChallenging

Scenario 2: Insertional Tendinopathy

EXAMINER

"A 45-year-old woman presents with posterior heel pain at the Achilles insertion. She has a prominent posterior heel bump. Pain is worse with stairs and inclines. Previous physiotherapy with eccentric exercises made her symptoms worse. X-ray shows a Haglund deformity and retrocalcaneal spurring."

EXCEPTIONAL ANSWER
This presentation suggests insertional Achilles tendinopathy with associated Haglund deformity, also known as pump bump. The key features distinguishing this from mid-portion disease include fixed tenderness at the insertion, radiographic findings of posterior calcaneal prominence and spurring, and importantly, the fact that eccentric exercises exacerbated her symptoms. This is typical for insertional disease where eccentric loading increases impingement. My conservative management would differ from mid-portion disease. I would recommend activity modification avoiding stairs and inclines, heel lifts to reduce dorsiflexion stress, footwear modification with open heel counters, and consider isometric loading instead of eccentric exercises. Extracorporeal shockwave therapy may be beneficial. If conservative measures fail after 4-6 months, I would discuss surgical intervention including central tendon-splitting approach, debridement of insertional calcification, Haglund resection, retrocalcaneal bursectomy, and reattachment with suture anchors if the insertion is detached.
KEY POINTS TO SCORE
Insertional disease responds poorly to eccentric exercises
Haglund deformity causes mechanical impingement
Footwear modification is important
Surgical approach differs from mid-portion disease
COMMON TRAPS
✗Prescribing aggressive eccentric exercises
✗Not recognizing the difference from mid-portion disease
✗Ignoring the Haglund deformity contribution
✗Not considering combined pathology
LIKELY FOLLOW-UPS
"What is a Haglund deformity?"
"How do you assess parallel pitch lines?"
"Would you ever do FHL transfer for insertional disease?"
VIVA SCENARIOChallenging

Scenario 3: Surgical Planning

EXAMINER

"A 40-year-old athlete presents after 9 months of failed conservative treatment for mid-portion Achilles tendinopathy. MRI shows extensive fusiform thickening with high T2 signal involving approximately 60% of the tendon cross-section. He wants to return to competitive sport."

EXCEPTIONAL ANSWER
After 9 months of failed conservative treatment, this patient meets criteria for surgical intervention. The MRI findings of 60% tendon involvement are significant for surgical planning. My approach would be open debridement through a medial incision to protect the sural nerve laterally. I would excise all degenerative tissue which, based on the MRI, will likely exceed 50% of the tendon. Following the 50% rule, I would plan for FHL transfer augmentation. The FHL is harvested from the master knot of Henry level, passed through a calcaneal tunnel, and fixed with an interference screw at 20 degrees plantarflexion. I would counsel that recovery involves 6 weeks in a walking boot, physiotherapy from week 6, and return to sport at 6-9 months. Expected success rates are 80-90%. I would discuss alternatives including continued conservative treatment, or proceeding with debridement alone accepting higher failure risk without augmentation.
KEY POINTS TO SCORE
50% debridement threshold for FHL transfer
FHL is in-phase with Achilles
Medial approach protects sural nerve
Return to sport at 6-9 months
COMMON TRAPS
✗Not planning for augmentation with greater than 50% debridement
✗Using lateral approach (sural nerve at risk)
✗Unrealistic return to sport expectations
✗Not counseling about alternative management
LIKELY FOLLOW-UPS
"What is the blood supply to the FHL?"
"How much toe flexion weakness can the patient expect?"
"What if the patient refuses FHL transfer?"

MCQ Practice Points

Watershed Zone

Q: What is the location of the watershed zone in the Achilles tendon and why is it clinically significant? A: The watershed zone is located 2-6cm proximal to the insertion. It has the poorest blood supply (peritendinous vessels only) and is where most mid-portion tendinopathy occurs.

Arc Sign Interpretation

Q: A patient has posterior heel pain. Tenderness moves distally when the ankle is dorsiflexed. What does this indicate? A: This is a positive arc sign, indicating mid-portion tendinopathy. A negative arc sign (fixed tenderness) indicates insertional disease.

Eccentric Protocol

Q: Describe the Alfredson eccentric exercise protocol for Achilles tendinopathy. A: 2 sets of 15 reps, twice daily, for 12 weeks, performed with both straight knee (gastrocnemius) AND bent knee (soleus). Patients should work through moderate pain (4-5/10).

FHL Transfer Indication

Q: When is FHL transfer indicated during Achilles debridement surgery? A: When more than 50% of the tendon requires debridement. FHL is in-phase (plantarflexor), has excellent tendon quality, and brings new blood supply.

Corticosteroid Contraindication

Q: Why are corticosteroid injections contraindicated in Achilles tendinopathy? A: Corticosteroids increase rupture risk, with highest risk in the first 4 weeks post-injection. They provide no long-term benefit for this degenerative condition.

Australian Context

Achilles tendinopathy is common in the active Australian population, with particular prevalence in running, tennis, and Australian rules football communities. The aging but active demographic contributes to increasing incidence of both insertional and non-insertional disease.

Sports Medicine Australia endorses eccentric loading protocols as first-line treatment, consistent with international evidence. Physiotherapy services for chronic tendinopathy may be accessed through Enhanced Primary Care plans in general practice settings. Surgical management is typically performed by foot and ankle subspecialists in metropolitan teaching hospitals.

Australian prescribers should be aware of the association between fluoroquinolone antibiotics and tendinopathy. The Therapeutic Goods Administration requires black box warnings on these medications highlighting tendon-related adverse effects, particularly in patients over 60 years or those taking corticosteroids.

Exam Cheat Sheet

Achilles Tendinopathy

High-Yield Exam Summary

Key Numbers

  • •Watershed zone: 2-6cm from insertion
  • •Eccentric protocol: 2x15 reps, twice daily, 12 weeks
  • •FHL transfer: If debriding more than 50% tendon
  • •Non-op success: 70-90% mid-portion, 50-60% insertional

Clinical Pearls

  • •Tendinosis NOT tendinitis - degenerative, minimal inflammation
  • •Arc sign positive = mid-portion (moves with dorsiflexion)
  • •Arc sign negative = insertional (fixed)
  • •Thompson test must be NORMAL (rules out complete rupture)

Treatment Principles

  • •Eccentric exercises first-line for mid-portion
  • •Insertional disease responds poorly to eccentric loading
  • •NEVER inject corticosteroids - rupture risk
  • •Surgery after 6 months failed conservative treatment

Surgical Points

  • •Medial approach protects sural nerve
  • •FHL transfer for greater than 50% debridement
  • •FHL in-phase with Achilles (plantarflexor)
  • •Central tendon-splitting for insertional surgery

Exam Traps

  • •Steroid injection recommendation
  • •Not knowing Alfredson protocol details
  • •Confusing insertional and mid-portion treatment
  • •Operating too early or too late
Quick Stats
Reading Time90 min
Related Topics

AC Joint Injuries in Athletes

Anterior Cruciate Ligament Injuries

Anterior Shoulder Instability

Articular Cartilage Injuries